- Home
- OST vs CYCC Comparison
OST vs CYCC Comparison
Compare OST & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- CYCC
- Stock Information
- Founded
- OST 2010
- CYCC 1992
- Country
- OST China
- CYCC Malaysia
- Employees
- OST N/A
- CYCC N/A
- Industry
- OST Industrial Machinery/Components
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- OST Technology
- CYCC Health Care
- Exchange
- OST Nasdaq
- CYCC Nasdaq
- Market Cap
- OST 15.7M
- CYCC 17.5M
- IPO Year
- OST 2022
- CYCC N/A
- Fundamental
- Price
- OST $1.66
- CYCC $7.12
- Analyst Decision
- OST
- CYCC
- Analyst Count
- OST 0
- CYCC 0
- Target Price
- OST N/A
- CYCC N/A
- AVG Volume (30 Days)
- OST 185.8K
- CYCC 86.9K
- Earning Date
- OST 09-19-2025
- CYCC 08-13-2025
- Dividend Yield
- OST N/A
- CYCC N/A
- EPS Growth
- OST N/A
- CYCC N/A
- EPS
- OST N/A
- CYCC N/A
- Revenue
- OST $38,333,251.00
- CYCC $10,000.00
- Revenue This Year
- OST N/A
- CYCC $137.21
- Revenue Next Year
- OST N/A
- CYCC N/A
- P/E Ratio
- OST N/A
- CYCC N/A
- Revenue Growth
- OST 0.34
- CYCC N/A
- 52 Week Low
- OST $1.35
- CYCC $3.08
- 52 Week High
- OST $235.00
- CYCC $597.60
- Technical
- Relative Strength Index (RSI)
- OST 26.79
- CYCC 41.06
- Support Level
- OST $1.50
- CYCC $7.30
- Resistance Level
- OST $2.07
- CYCC $8.82
- Average True Range (ATR)
- OST 0.23
- CYCC 0.63
- MACD
- OST 1.49
- CYCC 0.03
- Stochastic Oscillator
- OST 19.14
- CYCC 17.87
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.